Circulating innate immune markers and outcomes in treatment-na ïve advanced non–small cell lung cancer patients

Innate immunity represents the first step of activation of the immune system and dictates the quality of adaptive immune responses. Studies have reported links between systemic inflammatory or innate immune markers and prognosis in patients with lung cancer. To our knowledge, the prospective and concomitant study of these systemic markers has never been performed.

Source: European Journal of Cancer - January 14, 2019 Category: Cancer & Oncology Authors: M. Charrier, L. Mezquita, B. Lueza, L. Dupraz, D. Planchard, J. Remon, C. Caramella, L. Cassard, L. Boselli, K.S. Reiners, E. Pogge von Strandmann, S. Rusakiewicz, R. Ferrara, B. Duchemann, M. Naigeon, J.P. Pignon, B. Besse, N. Chaput Tags: Original Research Source Type: research